1-(BETA-D-RIBOFURANOSYL)-7-(4-BrOMOPHENYL)-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE
Compound with spectra: 1 NMR
![1-(BETA-D-RIBOFURANOSYL)-7-(4-BrOMOPHENYL)-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE](/api/compound/FhQBMYb3lRN.png?ph=true&h=300&w=458 "1-(BETA-D-RIBOFURANOSYL)-7-(4-BrOMOPHENYL)-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE")
| SpectraBase Compound ID | FhQBMYb3lRN |
|---|---|
| InChI | InChI=1S/C17H15BrN2O6S/c18-8-3-1-7(2-4-8)9-6-27-14-11(9)20(17(25)19-15(14)24)16-13(23)12(22)10(5-21)26-16/h1-4,6,10,12-13,16,21-23H,5H2,(H,19,24,25)/t10-,12-,13-,16-/m1/s1 |
| InChIKey | KUNHBNNFARCKIE-XNIJJKJLSA-N |
| Mol Weight | 455.28 g/mol |
| Molecular Formula | C17H15BrN2O6S |
| Exact Mass | 453.98342 g/mol |
| Enantiomer InChIKey | KUNHBNNFARCKIE-SDPXSBNPSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-(BETA-D-RIBOFURANOSYL)-7-(4-FLUOROPHENYL)-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE
1-(2,3-O-ISOPROPYLIDENE-5-O-METHANESULFONYL-BETA-D-RIBOFURANOSYL)-THIENO-[3.2-D]-PYRIMIDINE-2,4-DIONE
1-(5-DEOXY-2,3-O-ISOPROPYLIDENE-5-FLUORO-BETA-D-RIBOFURANOSYL)-THIENO-[3.2-D]-PYRIMIDINE-2,4-DIONE
2-((3-(3-bromophenyl)-4-oxo-4,6-dihydro-3H-spiro[benzo[h]quinazoline-5,1'-cyclohexan]-2-yl)thio)acetamide
9-methyl-2-{5-[(4-nitro-1H-pyrazol-1-yl)methyl]-2-furyl}-7-(trifluoromethyl)-2,3-dihydropyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4(1H)-one
ENT-GUIBOURTINIDOL-(4-BETA->6)-CATECHIN
1-(3-C-ALLYL-3,5-DI-O-BENZYL-2-O-METHYLSULFONYL-BETA-D-RIBOFURANOSYL)-THYMINE
CHAETOXANTHONE_A
RAPAMYCIN-42-[2-(4,5-DIMETHYLTHIAZOLIUM-3-YL)-ACETIC-ACID]-BROMIDE
8,9-DIMETHOXY-3,10B-DIPHENYL-1,2,4-OXADIAZOLO-[4,5-C]-[1,3]-BENZOTHIAZINE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of thieno[3,2-d]pyrimidine-2,4-diones cyclic and acyclic nucleosides as potential anti HIV agents | Journal of Heterocyclic Chemistry | 1994 |